The EPS decline likely left investors hesitant, as Sino Biopharmaceutical's performance, with a 34% loss including dividends, underperformed the broader market's 16% loss. This may signal unresolved challenges, given it's worse than the 6% annualised loss over the last half decade.
Sino Biopharmaceutical Limited's high P/S ratio may not be justified due to its slower revenue growth. Investors may hope for a business turnaround, but analysts lack confidence. The weak revenue outlook could risk the share price and shareholder investments.
Company's declining EPS, below market expectations, may have deterred investors. Past performance led to total loss for shareholders, raising future concerns. Dividend payouts, assumed reinvested, helped offset some losses.
Key points: 1. Hang Seng Index fell 2.57% in the first two weeks (2023/05/22 to 2023/06/02), with all 12 Hang Seng industries falling. Among them, the Hang Seng healthcare sector fell 1.51%, outperforming the Hang Seng Index by 1.06 percentage points, ranking third among the 12 Hang Seng industries 2. On May 22, the results of the f...
SINO BIOPHARMACEUTに関するコメント
HSI Opens 109 pts Lower as WUXI Series Slip
$無錫薬明康徳(02359.HK)$ , whose net profit rose 21% in 2023, delayed two placing-funded investment projects by 2 years to the end of 2025, and its share price lost 2.8% to $41.55, while its sa...
HSI Closes at 17,406, Up 7 pts; HSTI Closes at 3,854, Up 48 pts; PSBC Down over 6%; XIAOMI, LENOVO GROUP Hit New Highs
Active Heavyweights:
$中国建設銀行(00939.HK)$ closed at $4.48, down 1.8%
$テンセント(00700.HK)$ closed at $295.4, up 0.9%
$美団点評(03690.HK)$ closed at $...
HSI Up 272 pts; HSTI Up 58 pts; SENSETIME-W Up over 6%
HSI & HSCEI Constituents on Move:
$会徳豊(00020.HK)$ closed at $1.43, up 6.7%
$阿里健康信息(00241.HK)$ closed at $4.8, up 4.1%
$龍湖集団(00960.HK)$ closed at $13.42, up 3.4%
$中国生物製薬(01177.HK)$ clos...
コラムAnxin International - Pharmaceutical Industry Biweekly Report: The results of Chinese medicine decoction pieces combined selection landing, 2023ASCO abstract released
1. Hang Seng Index fell 2.57% in the first two weeks (2023/05/22 to 2023/06/02), with all 12 Hang Seng industries falling. Among them, the Hang Seng healthcare sector fell 1.51%, outperforming the Hang Seng Index by 1.06 percentage points, ranking third among the 12 Hang Seng industries
2. On May 22, the results of the f...
HSI Slides 342 Pts; Techs & Pharmas Gloom
Techs slid as the market continued to be watchful of the Sino-US relations:
$阿里巴巴集団(09988.HK)$ dived 3.2% to $84.1.
$テンセント(00700.HK)$ sank 1.9% to $338.4.
$美団点評(03690.HK)$ , $小米集団(01810.HK)$ , ...
まだコメントはありません